Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126197441 | 12619744 | 1 | I | 20160606 | 20160726 | 20160803 | 20160803 | EXP | PHHY2016IT104634 | SANDOZ | 87.03 | YR | F | Y | 0.00000 | 20160803 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126197441 | 12619744 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 125 MG, QD | 4625 | MG | 18569 | 125 | MG | TABLET | QD | ||||
| 126197441 | 12619744 | 2 | C | ASCRIPTIN | ASPIRIN | 1 | Oral | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126197441 | 12619744 | 1 | Gravitational oedema |
| 126197441 | 12619744 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126197441 | 12619744 | HO |
| 126197441 | 12619744 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126197441 | 12619744 | Acute kidney injury | |
| 126197441 | 12619744 | Asthenia | |
| 126197441 | 12619744 | Hypokalaemia | |
| 126197441 | 12619744 | Metabolic alkalosis | |
| 126197441 | 12619744 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126197441 | 12619744 | 1 | 20160501 | 20160606 | 0 |